Sponsor or institution

Clinical trials and research at Ipsen

• 15Clinical trials
• 39Countries

Newest trials

All recruiting trials (15)

• Corabotase for glabellar lines in adults

  A single-dose injection of corabotase (IPN10200) or placebo will be tested in adults with moderate to severe wrinkle-like lines between the eyebrows to see if it improves the lines and remains safe.

  Recruiting at 2 sites Phase 3 Ipsen · Guangzhou, Guangdong and 8 other locations · NCT07779252

• Odevixibat for PFIC in China: Real-world Safety and Effectiveness

  This registry collects real-world safety and effectiveness data on children with PFIC who are being treated with odevixibat in China.

  Recruiting at 2 sites Ipsen · Beijing and 5 other locations · NCT07588880

• See if odevixibat stays safe for kids and adults with Alagille syndrome over the long term

  This study tests whether continuing odevixibat is safe for people with Alagille syndrome who already take the drug in real life.

  Recruiting at 3 sites Ipsen · Bron and 13 other locations · NCT07585097

• Elafibranor Pregnancy Safety Registry

  This is an observational program to see if elafibranor exposure before or during pregnancy is safe for mothers and babies.

  Recruiting Ipsen · Wilmington, North Carolina · NCT07556913

• Elafibranor for adults with primary sclerosing cholangitis

  This trial will see if taking elafibranor once daily helps adults with primary sclerosing cholangitis compared with a placebo.

  Recruiting at 41 sites Phase 3 Ipsen · Chandler, Arizona and 230 other locations · NCT07387549

• Cabozantinib for adults with previously treated neuroendocrine tumors

  This study will see how cabozantinib works and how safe it is for adults with neuroendocrine tumors that have continued to grow after prior systemic treatment.

  Recruiting at 23 sites Ipsen · Graz and 40 other locations · NCT07314164

• IPN01203 for adults with advanced or metastatic solid tumors after immune checkpoint therapy

  We will test whether the experimental drug IPN01203 is safe and can slow or stop tumor growth in adults with advanced or metastatic solid tumors who previously received immune checkpoint inhibitors.

  Recruiting at 10 sites Phase 1/2 Ipsen · Grand Rapids, Michigan and 9 other locations · NCT07213830

• Safety and anti-tumor activity of IPN60300 in adults with advanced or metastatic solid tumors

  This trial will test whether injections of IPN60300 are safe and can help control advanced or metastatic solid tumors in adults.

  Recruiting at 10 sites Phase 1/2 Ipsen · New Haven, Connecticut and 11 other locations · NCT07213817

• Long-term outcomes of odevixibat (Bylvay) for people with PFIC in South Korea

  This registry will see how well odevixibat controls symptoms and how safe it is over time for people with Progressive Familial Intrahepatic Cholestasis (PFIC) in South Korea.

  Recruiting at 2 sites Ipsen · Gyeongsang and 4 other locations · NCT07185919

• IPN10200 treatment for cervical dystonia in adults

  This trial will test whether a single injection of IPN10200 (one of two doses) reduces neck posture problems, pain, and disability better than placebo in adults with cervical dystonia.

  Recruiting at 27 sites Phase 2 Ipsen · Tucson, Arizona and 44 other locations · NCT06937931

• Observing the long-term effects of odevixibat in patients with Alagille syndrome

  This study looks at how well the medication odevixibat works and its safety for people with Alagille syndrome over a long period of time by collecting their real-life experiences.

  Recruiting at 9 sites Ipsen · Los Angeles, California and 9 other locations · NCT06850038

• Monitoring the safety of odevixibat during pregnancy and breastfeeding

  This study is looking to see if the medication odevixibat is safe for mothers and their babies during pregnancy and breastfeeding.

  Recruiting Ipsen · Wilmington, North Carolina · NCT06258902

• Documenting long-term safety and effectiveness of palovarotene in patients with fibrodysplasia ossificans progressiva

  This study is trying to see how safe and effective the medication palovarotene is for children and adults with fibrodysplasia ossificans progressiva who are already using it.

  Recruiting at 4 sites Ipsen · San Francisco, California and 4 other locations · NCT06089616

• Long-term treatment with elafibranor for adults with primary biliary cholangitis

  This study is testing if the medication elafibranor can help adults with primary biliary cholangitis and cirrhosis avoid getting worse and needing a liver transplant or facing death.

  Recruiting at 140 sites Phase 3 Ipsen · Tucson, Arizona and 197 other locations · NCT06016842

• IPN10200 treatment for adult upper limb spasticity after stroke or TBI

  This trial will test whether different doses of IPN10200 can reduce upper limb spasticity in adults after stroke or traumatic brain injury while monitoring safety.

  Recruiting at 54 sites Phase 1/2 Ipsen · Downey, California and 80 other locations · NCT04752774

Quick answers

How many clinical trials run by Ipsen are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 39 countries. The most sites are in United States (10 trials), France (7 trials), Spain (6 trials), Italy (5 trials), Canada (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 1/2: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →